Title: P1.07-006 Altered Expression of Programmed Death-1 Receptor (PD-1) and Its Ligand PD-L1, PD-L2 after Neo-Adjuvant Chemotherapy in Lung Cancer
Abstract: Immunotherapy is a new research direction in the treatment of lung cancer. PD1/PD-L1, PD-L2 pathway as representative of the immune checkpoint, play critical roles in the development and progression of cancer. And the expression of PD-1, PD-L1, PD-L2 were associated with therapeutic effect. Many studies have shown that many factors may affect the expression of PD1, PD-L1, PD-L2, such as chemotherapy. The present study aims to examine the impact of neo-adjuvant chemotherapy (NAC) on PD-1, PD-L1, PD-L2 expression in lung cancer.
Publication Year: 2017
Publication Date: 2017-11-01
Language: en
Type: article
Indexed In: ['crossref']
Access and Citation
Cited By Count: 1
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot